Published on New York State Department of Health, Wadsworth Center (https://www.wadsworth.org[1])

HRSB Resources and Publications [3]

HRSB Biennial Reports

Utilization of Breast Cancer Research and Education Funds Reports

Related Links​[22]

External Publications

Since 1996, the HRSB’s mission has been to support innovative breast cancer scientific research and education projects within New York State. HRSB has recommended approximately $27 million in research awards through 2025 to some of New York State's finest research teams. Research listed in the table below is a result of this funding.

OrganizationInvestigator(s)Link/PubMed ID#Publication/Abstract Title
Stony Brook UniversityChung, Jun38201253[31]The Sensitization of Triple-Negative Breast Cancers to Poly ADP Ribose Polymerase Inhibition Independent of BRCA1/2 Mutation Status by Chemicall Modified microRNA-489
Stony Brook UniversityChung, Jun39201393[32]Recent Technologies towards Diagnostic and Therapeutic Applications of Circulating Nucleic Acids in Colorectal Cancers
Albany Medical CollegeBarroso, Margarida39642392[33]Modeling intratumor heterogeneity in breast cancer
Albany Medical CollegeBarroso, Margarida13484512[34]Iron–endoplasmic reticulum–extracellular matrix axis regulates cancer cell invasion
Icahn School of Medicine at Mount SinaiIrie, Hanna39541980[35]A PROTAC degrader suppresses oncogenic functions of PTK6 inducing apoptosis of breast cancer cells
Icahn School of Medicine at Mount SinaiSilva, Jose34633138[36]miR-424/503 modulates Wnt/β-catenin signaling in the mammary epithelium by targeting LRP6
New York UniversityDavid, GregorybioRxiv[37]The chromatin associated Sin3B is a critical regulator of DNA damage repair through the engagement of the Non-Homologous End Joining pathway
New York UniversityDavid, GregorybioRxiv[38]Lipocalin 2 upregulation mediates the detrimental effects of therapy-induced senescence in breast cancer cells
New York UniversityDavid, Gregory35500379[39]The origins of cancer cell dormancy
New York UniversityDavid, Gregory37314748[40]Chromatin-associated SIN3B protects cancer cells from genotoxic stress-induced apoptosis and dictates DNA damage repair pathway choice
New York UniversityDavid, Gregory35953598[41]Therapy-induced senescence promotes breast cancer cells plasticity by inducing Lipocalin-2 expression. 
Stony Brook UniversityChung, Jun38201253[42]The Sensitization of Triple-Negative Breast Cancers to Poly ADP Ribose Polymerase Inhibition Independent of BRCA1/2 Mutation Status by Chemically Modified microRNA-489
Stony Brook UniversityChung, Jun37892162[43]Combination Treatment Strategies to Overcome PARP Inhibitor Resistance
Stony Brook UniversityChung, Jun39201393[44]Recent Technologies towards Diagnostic and Therapeutic Applications of Circulating Nucleic Acids in Colorectal Cancers
Albany Medical CollegeBarroso, Margarida39642392[45]Modeling intratumor heterogeneity in breast cancer
Source URL: https://www.wadsworth.org/extramural/breastcancer/resources[46]
Links:
  1. https://www.wadsworth.org/extramural/breastcancer/resources[47]
  2. https://www.wadsworth.org/sites/default/files/WebDoc/Health%20Research%20Science%20Board%20Biennial%20Report%202017-2018.pdf[48]
  3. https://www.wadsworth.org/sites/default/files/WebDoc/2015-2016%20HRSB%20Biennial%20Report%20Final%20Approved.pdf[49]
  4. https://www.wadsworth.org/sites/default/files/WebDoc/1297229708/Final%20Approved%202013-2014%20HRSB%20Biennial%20Report.pdf[50]
  5. https://www.wadsworth.org/sites/default/files/WebDoc/1014675154/HRSB1112BiReport.pdf[51]
  6. https://www.wadsworth.org/sites/default/files/WebDoc/614230260/HRSB0910BiReport.pdf[52]
  7. https://www.wadsworth.org/sites/default/files/WebDoc/167586654/HRSB0708BiReport.pdf[53]
  8. https://www.wadsworth.org/sites/default/files/WebDoc/1161721496/HRSB0506BiReport.pdf[54]
  9. https://www.wadsworth.org/sites/default/files/2026-09/Utilization%20of%20Breast%20Cancer%20Research%20and%20Education%20Funds%20%20FINAL.pdf[55]
  10. https://www.wadsworth.org/sites/default/files/2025-12/HRSB%202024%20Utlization%20of%20Funds%20Report_FINAL.pdf[56]
  11. https://www.wadsworth.org/sites/default/files/2025-02/2023%20Breast%20Cancer%20Research%20Utilziation%20of%20Funds.pdf[57]
  12. https://www.wadsworth.org/sites/default/files/2025-02/HRSB%202022%20Utilization%20of%20Funds%20%20Report_Final.pdf[58]
  13. https://www.wadsworth.org/sites/default/files/2025-02/HRSB%202021%20Utlization%20of%20Funds_FINAL.pdf[59]
  14. https://www.wadsworth.org/sites/default/files/2025-02/2020_HRSB_Utilization%20of%20Funds%20Report_Final.pdf[60]
  15. https://www.wadsworth.org/sites/default/files/WebDoc/Final%20Approved%202019%20Utilization%20of%20BCREF%20Report%20%26%20Cash%20Utilization%20Table.pdf[61]
  16. https://www.wadsworth.org/sites/default/files/WebDoc/HRSB%202018%20Utilization%20of%20Funds%20Report.pdf[62]
  17. https://www.wadsworth.org/sites/default/files/WebDoc/HRSB%202017%20Utilization%20of%20Funds%20Report.pdf[63]
  18. https://www.wadsworth.org/sites/default/files/WebDoc/2016%20Report%20on%20the%20Utilization%20of%20Breast%20Cancer%20Research%20and%20Education%20Funds_0.pdf[64]
  19. https://www.wadsworth.org/sites/default/files/WebDoc/2015%20Report%20on%20the%20Utilization%20of%20Breast%20Cancer%20Research%20and%20Education%20Funds.pdf[65]
  20. http://iom.nationalacademies.org/Reports/2005/Spinal-Cord-Injury-Progress-Promise-and-Priorities.aspx[66]
  21. http://www.health.ny.gov/funding/[67]
  22. http://www.dec.ny.gov/chemical/27506.html[68]
  23. https://psur.cce.cornell.edu/[69]
  24. https://grantsreform.ny.gov/[70]
  25. http://www.sfs.ny.gov/[71]
  26. http://www.nih.gov[72]
  27. https://clinicaltrials.gov/[73]
  28. http://www.ncbi.nlm.nih.gov/pubmed[74]
  29. https://pubmed.ncbi.nlm.nih.gov/38201253/[75]
  30. https://pubmed.ncbi.nlm.nih.gov/39201393/[76]
  31. https://pubmed.ncbi.nlm.nih.gov/39642392/[77]
  32. https://pmc.ncbi.nlm.nih.gov/articles/PMC13484512/[78]
  33. https://pubmed.ncbi.nlm.nih.gov/39541980/[79]
  34. https://pubmed.ncbi.nlm.nih.gov/34633138/[80]
  35. https://www.biorxiv.org/content/10.1101/2022.03.09.483624v1[81]
  36. https://www.biorxiv.org/content/10.1101/2022.03.08.483463v2[82]
  37. https://pubmed.ncbi.nlm.nih.gov/35500379/[83]
  38. https://pubmed.ncbi.nlm.nih.gov/37314748/[84]
  39. https://pubmed.ncbi.nlm.nih.gov/35953598/[85]
  40. https://pubmed.ncbi.nlm.nih.gov/38201253/[86]
  41. https://pubmed.ncbi.nlm.nih.gov/37892162/[87]
  42. https://pubmed.ncbi.nlm.nih.gov/39201393/[88]
  43. https://pubmed.ncbi.nlm.nih.gov/39642392/[89]